AN2 Therapeutics News and Activities

AN2 Therapeutics is one of the...

• Russell 3000;
• TOB Iconic 10,000.

AN2 Therapeutics is a company listed under the stock ticker ANTX (US).

View the org chart displaying its 13 main executives

Most searched biographies at AN2 Therapeutics

• Eric Easom, Chief Executive Officer and Chairman of the Board
• Patricia Martin, Member of Board of Directors
• Lynn Marks, Director

Create your alert
to follow the executive moves at AN2 Therapeutics.

AN2 Therapeutics has 1,920 competitors including Sanofi (France), Moderna (United States (USA)) and Eli Lilly (United States (USA)).

Popular M&A news in Pharmaceuticals

• Samsung Biologics has announced the acquisition of PolyPeptide Group  (posted on July 22 2026).
• Ipsen has acquired Memo Therapeutics (posted on July 22 2026).
• Eli Lilly has announced the acquisition of AtaiBeckley  (posted on July 17 2026).

Popular contacts in Pharmaceuticals

• David Ricks - President, Chief Executive Officer and Chairman of the Board at Eli Lilly
• Richard Saynor - Chief Executive Officer at Sandoz
• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson

Learn more about the Pharmaceuticals industry

Press releases by AN2 Therapeutics

• Press Releases | AN2 Therapeutics, Inc
• AN2 Therapeutics Appoints Dr. Mel Spigelman, M.D. to its Board of Directors
• AN2 Therapeutics Announces Epetraborole Granted Orphan Drug Designation in the U.S. for the Treatment of Infections Caused by Non-Tuberculous Mycobacteria
• AN2 Therapeutics Reports Phase 1b Data for Oral Epetraborole
• AN2 Therapeutics Provides Regulatory Update
• AN2 Therapeutics Launches with $12 Million in Series A
• Latest News | Media Contact | AN2 Therapeutics
• AN2 Therapeutics Closed $80 Million Series B Financing
• View more press releases Close

Social media about AN2 Therapeutics

• AN2 Therapeutics on Wikipedia, Google News & Yahoo Finance
• AN2 Therapeutics on LinkedIn, X (Twitter) & YouTube